Verdad Advisers »

Ultragenyx Pharmaceutical shares owned by Verdad Advisers

Quarter-by-quarter ownership of Ultragenyx Pharmaceutical (RARE) shares owned by Verdad Advisers from 13F filings

Historical chart of Verdad Advisers investment in Ultragenyx Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Ultragenyx Pharmaceutical held by Verdad Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ultragenyx Pharmaceutical by Verdad Advisers

Quarter filed Position value Share count Share price at filing
2026-06-30 $208k 6.2k 33.39

More positions owned by Verdad Advisers

Apple (AAPL)
Belite Bio Sponsored Ads (BLTE)
ACADIA Pharmaceuticals (ACAD)
Comcast Corp Cl A (CMCSA)
Chatham Lodging Trust (CLDT)
Tenax Therapeutics Com New (TENX)
Slide Ins Hldgs (SLDE)
Zymeworks Del (ZYME)
AMN Healthcare Services (AMN)
X4 Pharmaceuticals Com New (XFOR)
Versant Media Group Com Cl A (VSNT)
NetScout Systems (NTCT)
Aadi Bioscience (WHWK)
Johnson & Johnson (JNJ)
Contineum Therapeutics Cl A (CTNM)

View all positions for Verdad Advisers

Top funds holding Ultragenyx Pharmaceutical

BlackRock
Rtw Investments
Vanguard Portfolio Management
AQR Capital Management
State Street Corporation
Vanguard Capital Management
Two Sigma Investments
Sands Capital Management
Jacobs Levy Equity Management
Frontier Capital Management
Geode Capital Management
Sofinnova Ventures
Bellevue Group
D. E. Shaw & Co
Adage Capital Partners GP

View all funds holding Ultragenyx Pharmaceutical